Speeding up the implementation of "two ticket system" in local medicine circulation industry

Source: on November 4, 2016, the office of Fujian Medical Security Management Committee issued the notice on further cracking down on cheating medical security funds and infringing on patients' rights and interests (hereinafter referred to as the "notice") to clarify whether the pharmaceutical consumables supply and production enterprises and distribution enterprises will not implement the "two vote system" once there is any Or bribery of medical staff, will enter the "blacklist", be disqualified from supply or distribution It is worth noting that Fujian is the only province in China that has fully implemented the "two ticket system" Since July 2012, the "two ticket system + distribution business integration" has changed the market ecology of pharmaceutical circulation in Fujian Province The so-called "two ticket system" requires that drugs can only be invoiced twice before they are circulated to consumers In other words, the number of turnover in the circulation field cannot exceed twice Among them, pharmaceutical companies issue invoices to pharmaceutical distribution (commercial) companies once when they deliver drugs, and pharmaceutical distribution companies issue invoices again after they deliver drugs to medical institutions The purpose of "two ticket system" is to optimize the order of drug purchase and sale and to compress the circulation In April this year, the State Council issued a document asking the pilot provinces of medical reform to promote the "two vote system" in a full range, encouraging one vote system, direct settlement of payments by hospitals and pharmaceutical manufacturers, and calculation of distribution costs by pharmaceutical and distribution enterprises Up to now, there are 11 pilot provinces of national medical reform Since then, the implementation of "two vote system" has accelerated Up to now, except for Fujian, Anhui and Shaanxi have made clear the implementation time of "two vote system" On October 8, the food and Drug Administration of Anhui Province, in conjunction with the health and Family Planning Commission and other departments in the province, issued a document, planning to implement the "two vote system" in the province from November 1 The notice on deepening the reform of the supply guarantee system for pharmaceutical consumables issued by Shaanxi Province requires the formulation of specific implementation opinions on "two vote system", which will be implemented from January 2017 In addition, Jiangsu, Hunan, Zhejiang, Hebei and other provinces have also introduced policies related to the "two vote system" Wu Zhen, deputy director of the State Food and drug administration, recently proposed that the idea of implementing the "two vote system" by the drug regulatory authorities should be to take the drug manufacturing enterprises as the starting point, completely eliminate the small wholesale enterprises that rely on the above-mentioned illegal behaviors for profit and threaten the drug safety For the necessity of implementing the "two vote system", Wu Zhen said frankly that the whole Chinese drug market is less than 2 trillion, but there are 12000 wholesale enterprises, 80% of the sales are concentrated in the top 100, and the remaining 10000 only share 20% According to the normal law of market economy, this part of wholesale enterprises will be eliminated naturally But they not only live, but they live well "What this paradox shows is that the law of market economy has failed in the field of drug circulation The superior cannot win, and the inferior cannot be eliminated." Wu Zhen said that through the "two vote system", we can squeeze out some of the past affiliated and walk tickets, that is to say, eliminate them, make the whole market clean, make the circulation process simple, reduce the cost, and really make the public and the people (51.000, 0.23, 0.45%) benefit A person in charge of a pharmaceutical enterprise said that the implementation of the "two ticket system" can minimize the circulation link, which is conducive to quality control; at the same time, large-scale, safe and reliable wholesale enterprises will be selected as drug distributors Therefore, large pharmaceutical commercial companies will usher in the good, small enterprises will gradually out In the past, those profit models came from the fast-moving companies that had passed and reversed tickets Without distribution entities and distribution capabilities, they would be out of business quickly Gu Xin, an expert in medical reform and a professor at the school of government management of Peking University, also pointed out that small and medium-sized pharmaceutical commercial enterprises, which live on "ticket scalping", "ticket passing" and "ticket passing", either fail, transform or be merged.